BRAF Apr 25 2025 FORTE: A Phase 2 Master Protocol Assessing Plixorafenib for BRAF-Altered Cancers Read more
BRAF Oct 17 2024 Safety & Efficacy of BRAF Inhibitor Plixorafenib in Children & Adults with Recurrent, BRAF altered PCNSTs Read more
BRAF Apr 17 2024 Paradox-Breaker BRAF inhibitor plixorafenib (FORE8394) synergizes with MEKi in BRAF V600 and non- V600 alterations Read more
BRAF Apr 17 2024 Safety & Efficacy of BRAF Inhibitor FORE8394 Patients w. Advanced Solid & CNS Tumors Read more
BRAF Apr 16 2024 Dose optimization of novel BRAF inhibitor FORE8394 based on PK and efficacy results Read more
KRAS Aug 15 2021 Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer Read more